Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine plus methylprednisolone versus epinephrine plus placebo during in-hospital cardiopulmonary resuscitation
IRCT20130812014333N127Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methylprednisolone and epinephrine in cardiac arrest (SCA) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Neurological complications and Hypertension. Started May 2019; status: completed.
02
Drugs
methylprednisoloneepinephrine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on IRCT20130812014333N127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N127.